Correlates of incarceration among young methamphetamine users in Chiang Mai, Thailand

American Journal of Public Health

Volumn 99, Issue 7, 2009, Pages 1232-1238

  Thomson, Nicholas ^a   Sutcliffe, Catherine G ^a   Sirirojn, Bangorn ^b   Keawvichit, Rassamee ^b   Wongworapat, Kanlaya ^b   Sintupat, Kamolrawee ^b   Aramrattana, Apinun ^b   Celentano, David D ^a  

^a JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^b CHIANG MAI UNIVERSITY   (Thailand)

Author keywords

[No Author keywords available]

Indexed keywords

METHAMPHETAMINE;

ADULT; ARTICLE; BLOOD SAMPLING; CHLAMYDIA TRACHOMATIS; CONTROLLED STUDY; DRUG ABUSE; DRUG DEPENDENCE; DRUNKENNESS; FEMALE; HEALTH SURVEY; HEPATITIS C; HERPES SIMPLEX VIRUS 2; HERPES VIRUS INFECTION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; MAJOR CLINICAL STUDY; MALE; NEISSERIA GONORRHOEAE; PRISON; SEXUAL BEHAVIOR; SEXUALLY TRANSMITTED DISEASE; TATTOOING; TREPONEMA PALLIDUM; TRICHOMONAS VAGINALIS; UNSAFE SEX; URINALYSIS; ADOLESCENT; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CROSS-SECTIONAL STUDY; HIGH RISK BEHAVIOR; POISSON DISTRIBUTION; PREVALENCE; PRISONER; RANDOMIZED CONTROLLED TRIAL; RISK FACTOR; THAILAND;

ADOLESCENT; AMPHETAMINE-RELATED DISORDERS; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; MALE; METHAMPHETAMINE; POISSON DISTRIBUTION; PREVALENCE; PRISONERS; RISK FACTORS; RISK-TAKING; SEXUALLY TRANSMITTED DISEASES; THAILAND; YOUNG ADULT;

EID: 67650708193     PISSN: 00900036     EISSN: 15410048     Source Type: Journal    
DOI: 10.2105/AJPH.2008.136648     Document Type: Article

References (51)

1. Acute public health consequences of methamphetamine laboratories-16 states, January 2000-June 2004. MMWR Morb MortalWkly Rep. 2005;54(14):356-359.
2. WHO. Amphetamine-Like Stimulants: A Report from the WHO Meeting on Amphetamines, MDMA and Other Psychostimulants. Geneva, Switzerland: Substance Abuse Department, World Health Organization; 1997.
3. Hall W, Hando J, Darke S, Ross J. Psychological morbidity and route of administration among amphetamine users in Sydney, Australia. Addiction. 1996;91(1):81-87.
4. Molitor F, Ruiz JD, Flynn N, Mikanda JN, Sun RK, Anderson R. Methamphetamine use and sexual and injection risk behaviors among out-of-treatment injection drug users. Am J Drug Alcohol Abuse. 1999;25(3):475-493.
5. Razak MH, Jittiwutikarn J, Suriyanon V, et al. HIV prevalence and risks among injection and noninjection drug users in northern Thailand: need for comprehensive HIV prevention programs. J Acquir Immune Defic Syndr. 2003;33(2):259-266.
6. Status of Substance Abuse: National Household Survey. Bangkok, Thailand: Academic Committee on Substance Abuse; 2003.
7. Kuratanavej S. Crime Prevention: Current Issues in Correctional Treatment and Effective Countermeasures. Tokyo, Japan: United Nations Asia and Far East Institute for the Prevention of Crime and the Treatment of Offenders; 2001. Resource Material Series 57.
8. Vongchak T, Kawichai S, Sherman SG, Celentano DD. The influence of Thailand's 2003 "war on drugs" policy on self-reported drug use among injection drugs users in Chiang Mai, Thailand. Int J Drug Policy. 2005;16:115-121.
9. Sherman S, Aramrattana A, Celentano D. Public health research in a human rights crisis: the effects of the Thai "war on drugs." In: Beyrer C, Pizer HF, eds. Public Health and Human Rights: Evidence-Based Approaches. Baltimore, MD: Johns Hopkins University Press; 2007:222-242.
10. Beyrer C, Jittiwutikarn J, Teokul W, et al. Drug use, increasing incarceration rates, and prison-associated HIV risks in Thailand. AIDS Behav. 2003;7(2):153-161.
11. Kuratanavej S. Treatment and Rehabilitation Initiatives in Asian Cities. Paper presented at: The 2nd Asian Cities Against Drugs (ASCAD) Conference; September 12-15, 2005; Palawan, Philippines.
12. Patterns and Trends of Amphetamine-Type Stimulants (ATS) and Other Drugs of Abuse in East Asia and the Pacific 2006. New York, NY: United Nations Office of Drug and Crime Regional Centre for East Asia and the Pacific; 2007.
13. Fleming DT, Levine WC, Trees DL, Tambe P, Toomey K, St Louis ME. Syphilis in Atlanta during an era of declining incidence. Sex Transm Dis. 2000;27(2):68-73.
14. Plitt SS, Sherman SG, Strathdee SA, Taha TE. Herpes simplex virus 2 and syphilis among young drug users in Baltimore, Maryland. Sex Transm Infect. 2005;81(3):248-253.
15. Choopanya K, Des Jarlais DC, Vanichseni S, et al. Incarceration and risk for HIV infection among injection drug users in Bangkok. J Acquir Immune Defic Syndr. 2002;29(1):86-94.
16. Zamani S, Kihara M, Gouya MM, et al. High prevalence of HIV infection associated with incarceration among community-based injecting drug users in Tehran, Iran. J Acquir Immune Defic Syndr. 2006;42(3):342-346.
17. Maher L, Chant K, Jalaludin B, Sargent P. Risk behaviors and antibody hepatitis B and C prevalence among injecting drug users in south-western Sydney, Australia. J Gastroenterol Hepatol. 2004;19(10):1114-1120.
18. Samuel MC, Doherty PM, Bulterys M, Jenison SA. Association between heroin use, needle sharing, and tattoos received in prison with hepatitis B and C positivity among street-recruited injecting drug users in New Mexico, USA. Epidemiol Infect. 2001;127(3):475-484.
19. Jittiwutikarn J, Thongsawat S, Suriyanon V, et al. Hepatitis C infection among drug users in northern Thailand. Am J Trop Med Hyg. 2006;74(6):1111-1116.
20. Firestone Cruz M, Fischer B, Patra J, et al. Prevalence and associated factors of hepatitis C infection (HCV) in a multi-site Canadian population of illicit opioid and other drug users (OPICAN). Can J Public Health. 2007;98(2):130-133.
21. Samuel MC, Bulterys M, Jenison S, Doherty P. Tattoos, incarceration and hepatitis B and C among street-recruited injection drug users in New Mexico, USA: update. Epidemiol Infect. 2005;133(6):1146-1148.
22. Thaisri H, Lerwitworapong J, Vongsheree S, et al. HIV infection and risk factors among Bangkok prisoners, Thailand: a prospective cohort study. BMC Infect Dis. 2003;28 3:25.
23. Guimaraes T, Granato CF, Varella D, Ferraz ML, Castelo A, Kallas EG. High prevalence of hepatitis C infection in a Brazilian prison: identification of risk factors for infection. Braz J Infect Dis. 2001;5(3):111-118.
24. Blank S, Sternberg M, Neylans LL, Rubin SR, Weisfuse IB, St Louis ME. Incident syphilis among women with multiple admissions to jail in New York City. J Infect Dis. 1999;180(4):1159-1163.
25. Calzavara L, Ramuscak N, Burchell AN, et al. Prevalence of HIV and hepatitis C virus infections among inmates of Ontario remand facilities. CMAJ. 2007;177:257-261.
26. Fox RK, Currie SL, Evans J, et al. Hepatitis C virus infection among prisoners in the California state correctional system. Clin Infect Dis. 2005;15 41(2):177-186.
27. Wilson D, Ford N, Ngammee V, Chua A, Kyaw MK. HIV prevention, care, and treatment in two prisons in Thailand. PLoS Med. 2007;26 4(6):e204.
28. Buavirat A, Page-Shafer K, van Griensven GJ, et al. Risk of prevalent HIV infection associated with incarceration among injecting drug users in Bangkok, Thailand: case-control study. BMJ. 2003;326:308.
29. Hellard ME, Hocking JS, Crofts N. The prevalence and the risk behaviours associated with the transmission of hepatitis C virus in Australian correctional facilities. Epidemiol Infect. 2004;132(3):409-415.
30. Burattini M, Massad E, Rozman M, Azevedo R, Carvalho H. Correlation between HIV and HCV in Brazilian prisoners: evidence for parenteral transmission inside prison. Rev Saude Publica. 2000;34(5):431-436.
31. Stark K, Bienzle U, Vonk R, Guggenmoos-Holzmann I. History of syringe sharing in prison and risk of hepatitis B virus, hepatitis C virus, and human immunodeficiency virus infection among injecting drug users in Berlin. Int J Epidemiol. 1997;26(6):1359-1366.
32. Celentano DD, Sirirojn B, Sutcliffe CG, et al. Sexually transmitted infections and sexual and substance use correlates among young adults in Chiang Mai, Thailand. Sex Transm Dis. 2008;35(4):400-405.
33. Ewing JA. Detecting alcoholism. The CAGE questionnaire. JAMA. 1984;252:1905-1907.
34. Dawkins MP. Drug use and violent crime among adolescents. Adolescence. 1997;32(126):395-405.
35. Dawkins RL, Dawkins MP. Alcohol use and delinquency among Black, White and Hispanic adolescent offenders. Adolescence. 1983;18(72):799-809.
36. Watts WD, Wright LS. The relationship of alcohol, tobacco, marijuana, and other illegal drug use to delinquency among Mexican-American, Black, and White adolescent males. Adolescence. 1990;25(97):171-181.
37. Dembo R, Williams L, Wothke W, Schmeidler J. The relationships among family problems, friends' troubled behavior, and high-risk youths' alcohol/other drug use and delinquent behavior: a longitudinal study. Int J Addict. 1994;29(11):1419-1442.
38. Friedman AS, Kramer S, Kreisher C, Granick S. The relationships of substance abuse to illegal and violent behavior, in a community sample of young adult African American men and women (gender differences). J Subst Abuse. 1996;8:379-402.
39. Yen CF, Chong MY, Liu YH. Juvenile drug offenders who use amphetamine recommitted to a remand center: the role of psychiatric morbidity. Subst Use Misuse. 2003;38(1):141-150.
40. Weller SC. A meta-analysis of condom effectiveness in reducing sexually transmitted HIV. Soc Sci Med. 1993;36(12):1635-1644.
41. Haley RW, Fischer RP. Commercial tattooing as a potentially important source of hepatitis C infection. Clinical epidemiology of 626 consecutive patients unaware of their hepatitis C serologic status. Medicine (Baltimore). 2001;80:134-151.
42. Chongsrisawat V, Yoocharoen P, Theamboonlers A, et al. Hepatitis B seroprevalence in Thailand: 12 years after hepatitis B vaccine integration into the national expanded programme on immunization. Trop Med Int Health. 2006;11(10):1496-1502.
43. Bernstein KT, Chow JM, Ruiz J, et al. Chlamydia trachomatis and Neisseria gonorrhoeae infections among men and women entering California prisons. Am J Public Health. 2006;96(10):1862-1866.
44. Mertz KJ, Voigt RA, Hutchins K, Levine WC. Findings from STD screening of adolescents and adults entering corrections facilities: implications for STD control strategies. Sex Transm Dis. 2002;29(12):834-839.
45. From the Centers for Disease Control and Prevention. High prevalence of chlamydial and gonococcal infection in women entering jails and juvenile detention centers-Chicago, Birmingham, and San Francisco, 1998. JAMA. 1999;282(15):1417-1418.
46. Kelly PJ, Bair RM, Baillargeon J, German V. Risk behaviors and the prevalence of Chlamydia in a juvenile detention facility. Clin Pediatr (Phila). 2000;39:521-527.
47. de Ravello L, Brantley MD, Lamarre M, Qayad MG, Aubert H, Beck-Sague C. Sexually transmitted infections and other health conditions of women entering prison in Georgia, 1998-1999. Sex Transm Dis. 2005;32(4):247-251.
48. Yen CF, Yang YH, Chong MY. Correlates of methamphetamine use for Taiwanese adolescents. Psychiatry Clin Neurosci. 2006;60(2):160-167.
49. Trupin EW, Turner AP, Stewart D, Wood P. Transition planning and recidivism among mentally ill juvenile offenders. Behav Sci Law. 2004;22:599-610.
50. Wolff N. Community reintegration of prisoners with mental illness: a social investment perspective. Int J Law Psychiatry. 28(1):43-58, 2005.
51. Iguchi MY, London JA, Forge NG, Hickman L, Fain T, Riehman K. Elements of well-being affected by criminalizing the drug user. Public Health Rep. 2002;117(suppl 1):S146-S150.